CA1206904A - Antigen for detecting toxoplasmic immunity and the process for preparing same - Google Patents
Antigen for detecting toxoplasmic immunity and the process for preparing sameInfo
- Publication number
- CA1206904A CA1206904A CA000417915A CA417915A CA1206904A CA 1206904 A CA1206904 A CA 1206904A CA 000417915 A CA000417915 A CA 000417915A CA 417915 A CA417915 A CA 417915A CA 1206904 A CA1206904 A CA 1206904A
- Authority
- CA
- Canada
- Prior art keywords
- antigen
- toxoplasmic
- process according
- culture
- cell strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000427 antigen Substances 0.000 title claims abstract description 57
- 102000036639 antigens Human genes 0.000 title claims abstract description 50
- 108091007433 antigens Proteins 0.000 title claims abstract description 50
- 230000036039 immunity Effects 0.000 title claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 21
- 210000002966 serum Anatomy 0.000 claims abstract description 14
- 241000282414 Homo sapiens Species 0.000 claims abstract description 8
- 239000000725 suspension Substances 0.000 claims abstract description 8
- 230000001936 parietal effect Effects 0.000 claims abstract description 6
- 241000700199 Cavia porcellus Species 0.000 claims abstract description 5
- 206010020751 Hypersensitivity Diseases 0.000 claims abstract description 5
- 208000026935 allergic disease Diseases 0.000 claims abstract description 5
- 210000001840 diploid cell Anatomy 0.000 claims abstract description 5
- 230000009610 hypersensitivity Effects 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 26
- 210000004027 cell Anatomy 0.000 claims description 19
- 241000223996 Toxoplasma Species 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 11
- 239000002609 medium Substances 0.000 claims description 11
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 244000309466 calf Species 0.000 claims description 7
- 238000001514 detection method Methods 0.000 claims description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 6
- 229960004279 formaldehyde Drugs 0.000 claims description 6
- 235000019256 formaldehyde Nutrition 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 5
- 230000002779 inactivation Effects 0.000 claims description 5
- 241000223997 Toxoplasma gondii Species 0.000 claims description 4
- 230000001413 cellular effect Effects 0.000 claims description 4
- 239000001963 growth medium Substances 0.000 claims description 4
- 210000004102 animal cell Anatomy 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 238000000108 ultra-filtration Methods 0.000 claims description 3
- 230000003612 virological effect Effects 0.000 claims description 3
- 238000000502 dialysis Methods 0.000 claims description 2
- 230000000415 inactivating effect Effects 0.000 claims description 2
- 238000011081 inoculation Methods 0.000 claims description 2
- 238000012360 testing method Methods 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 241000282693 Cercopithecidae Species 0.000 description 3
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000009589 serological test Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 241000700198 Cavia Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 235000003332 Ilex aquifolium Nutrition 0.000 description 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 description 1
- 235000002294 Ilex volkensiana Nutrition 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 231100001221 nontumorigenic Toxicity 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000011045 prefiltration Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011110 re-filtration Methods 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8123565 | 1981-12-17 | ||
| FR8123565A FR2518407A1 (fr) | 1981-12-17 | 1981-12-17 | Nouvel antigene pour la recherche de l'immunite toxoplasmique et son procede de preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1206904A true CA1206904A (en) | 1986-07-02 |
Family
ID=9265121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000417915A Expired CA1206904A (en) | 1981-12-17 | 1982-12-16 | Antigen for detecting toxoplasmic immunity and the process for preparing same |
Country Status (11)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2564731B1 (fr) * | 1984-05-28 | 1986-10-10 | Ambroise Thomas Pierre | Nouvelles fractions exo-antigeniques toxoplasmiques, leur procede de preparation et leur application a la recherche de l'immunite toxoplasmique chez l'homme par tests cutanes |
| FR2618680B1 (fr) * | 1987-07-31 | 1990-05-11 | Pasteur Institut | Antigenes d'excretion-secretion specifiques de toxoplasma gondii, leurs produits d'expression, leur procede d'obtention et leurs applications diagnostiques et prophylactiques |
| FR2625099B1 (fr) * | 1987-12-24 | 1991-06-14 | Transgene Sa | Proteines et leur procede de preparation, sequences d'adn, anticorps et leur application, poxvirus, cellules transformees ou infectees et compositions pharmaceutiques utiles dans la prevention de la toxoplasmose |
| ES2342971T3 (es) | 2005-03-08 | 2010-07-20 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Antigenos recombinantes quimericos de toxoplasma gondii. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5444016A (en) * | 1977-09-13 | 1979-04-07 | Nippon Touketsu Kansou Kenkiyu | Latex coagulation and reaction reagent for detecting toxoplasma antibody and production thereof |
| FR2482980A1 (fr) * | 1980-05-20 | 1981-11-27 | Biomerieux Sa | Procede d'obtention de preparations de toxoplasmes pour le diagnostic de la toxoplasmose, et preparations ainsi obtenues |
-
1981
- 1981-12-17 FR FR8123565A patent/FR2518407A1/fr active Granted
-
1982
- 1982-12-02 AT AT82402197T patent/ATE14274T1/de active
- 1982-12-02 DE DE8282402197T patent/DE3264792D1/de not_active Expired
- 1982-12-02 EP EP82402197A patent/EP0082745B1/fr not_active Expired
- 1982-12-10 AR AR291563A patent/AR228806A1/es active
- 1982-12-10 AU AU91404/82A patent/AU554541B2/en not_active Ceased
- 1982-12-13 ES ES518127A patent/ES518127A0/es active Granted
- 1982-12-14 JP JP57217930A patent/JPS58126814A/ja active Pending
- 1982-12-14 FI FI824280A patent/FI71165C/fi not_active IP Right Cessation
- 1982-12-16 NO NO824242A patent/NO824242L/no unknown
- 1982-12-16 CA CA000417915A patent/CA1206904A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE3264792D1 (en) | 1985-08-22 |
| AU554541B2 (en) | 1986-08-28 |
| NO824242L (no) | 1983-06-20 |
| AR228806A1 (es) | 1983-04-15 |
| ATE14274T1 (de) | 1985-08-15 |
| JPS58126814A (ja) | 1983-07-28 |
| FR2518407A1 (fr) | 1983-06-24 |
| EP0082745B1 (fr) | 1985-07-17 |
| ES8308485A1 (es) | 1983-09-01 |
| FI824280A0 (fi) | 1982-12-14 |
| FI824280L (fi) | 1983-06-18 |
| FI71165C (fi) | 1986-11-24 |
| ES518127A0 (es) | 1983-09-01 |
| FR2518407B1 (enrdf_load_stackoverflow) | 1984-05-04 |
| AU9140482A (en) | 1983-06-23 |
| EP0082745A1 (fr) | 1983-06-29 |
| FI71165B (fi) | 1986-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Thor et al. | Cell migration inhibition factor released by antigen from human peripheral lymphocytes | |
| Provost et al. | Etiologic relationship of marmoset-propagated CR326 hepatitis A virus to hepatitis in man | |
| Nahmias et al. | Viral Leukocyte Interrelationships: I. Multiplication of a DNA Virus—Herpes Simplex—in Human Leukocyte Cultures | |
| Ahmed et al. | Demonstration of a blocking factor in the plasma and spinal fluid of patients with subacute sclerosing panencephalitis: I. Partial characterization | |
| US3699222A (en) | Production of viral interfering substances | |
| Barnothy et al. | Influence of a magnetic field upon the leucocytes of the mouse | |
| Feldman et al. | Cell interactions in the induction of antibody formation | |
| Paucker et al. | Purification, characterization, and attempts at isotopic labeling of mouse interferon | |
| CA1206904A (en) | Antigen for detecting toxoplasmic immunity and the process for preparing same | |
| Fujinami et al. | Failure to cleave measles virus fusion protein in lymphoid cells. A possible mechanism for viral persistence in lymphocytes | |
| Underwood et al. | Studies on Measles Virus in Tissue Culture: I. Growth Rates in Various Cells and Development of a Plaque Assay | |
| Redman et al. | Comparison of IgM and IgG anti-A and anti-B levels in Asian, Caucasian and Negro donors in the North West Thames Region | |
| Stromberg et al. | Development of larvae of Ascaris suum from the third to the fourth stage in a chemically defined medium | |
| Schmidt et al. | The complement-fixing antigen of rubella virus. | |
| Chappell et al. | Preparation of La Crosse virus hemagglutinating antigen in BHK-21 suspension cell cultures | |
| Buxton et al. | Primary and secondary responses of the ovine lymph node to Toxoplasma gondii: cell output in efferent lymph and parasite detection | |
| CN113278067B (zh) | 一种新型冠状病毒猪源性免疫球蛋白的制备方法 | |
| Abramoff et al. | Studies of the Chicken Immune Response: II. Biologic Activity of Spleen “Immunogenic RNA” | |
| JPS58109426A (ja) | サルモネラ菌による感染に対して有効な細菌ワクチンの製造法 | |
| Zweiman et al. | Effects of Non-Viable Measles Virus on Proliferating Human Lymphocytes: 2. Characteristics of the Suppressive Reaction | |
| US4654304A (en) | Composition for cell cultivation, production and use thereof | |
| ff Edward | Immunization against louping-ill. Immunization of man | |
| Fosberg et al. | Isolation and characterization of epizootic hemorrhagic disease virus from white-tailed deer (Odocoileus virginianus) in eastern Washington | |
| Klietmann et al. | Effectiveness and tolerance of preand postexposure treatment with purified inactivated rabies vaccine prepared on Vero cell line | |
| US3386882A (en) | Purified vaccine from brain tissue |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |